Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Apex MD vs Aurelius Health Group

Apex MD
Graded #87

Higher grade

vs+11
Aurelius Health Group
Graded #311

Lower grade

The verdict

Apex MD takes it — 71.8/100 to 60.8/100.

Apex MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Apex MD is a US virtual telemedicine platform licensed in all 50 states that prescribes compounded GLP-1 medications for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAurelius Health Group +6
48
54
Dose & formulationApex MD +31
83
52
Clinical oversightApex MD +2
78
76
Labs & monitoringApex MD +26
89
63
FulfillmentApex MD +21
82
61
Contract termsAurelius Health Group +6
55
61
Apex MD · left barAurelius Health Group · right bar

The numbers

MetricApex MDAurelius Health Group
WeighScore71.8/10060.8/100
GradeCC
Scorecard rank#87#311
Semaglutide$299/moNot disclosed
Tirzepatide$399/mo$199/mo (microdose tier, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Apex MD

Graded #87 · C

Strengths

  • Licensed in all 50 states
  • Unlimited provider visits and Labcorp labs included in the plan
  • Both semaglutide and tirzepatide, injectable or oral
  • Medication delivery typically in under four business days

Where it loses points

  • Compounds bundle NAD, B-12 and L-Carnitine rather than a single-ingredient GLP-1
  • Does not publicly name its compounding pharmacy or list an accreditation seal
Aurelius Health Group

Graded #311 · C

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Where it loses points

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose programme and nothing else — no labelled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labelled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard